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Bio-specific and bio-orthogonal chemistries to
switch-oﬀ the quencher of a FRET-based
fluorescent probe: application to living-cell
biothiol imaging†
C. Egloﬀ,a S. A. Jacques,a M. Nothisen,b D. Weltin,c C. Calligaro,c M. Mosser,a
J.-S. Remyb and A. Wagner*a
We report the first molecular system that is responsive to both a
bio-specific and a bio-orthogonal stimulus. This dual activation
process was applied to the design of a biothiol-specific FRET-
based fluorescent probe that could be turned-on via an original
concept of quencher bleaching.
The field of chemistry in living organisms has long been
focused on fine tuning of structural motifs’ reactivity in order
to achieve chemo-selective reaction with biological substrates
such as an endogenous reactive metabolite, an amino acid, a DNA
sequence, a ROS or acidic pH. This type of biospecific chemistry
has led to important developments in various domains such as
imaging probes,1 pathology specific pro-drugs2 or advanced bio-
materials.3 The idea of using exogenous reactants to trigger a
chemical reaction in a living organism (bio-orthogonal reaction)
appeared more recently and has nevertheless gained much
interest. Among the landmark studies, Meggers4 and later
Bradley5 showed that organometallic catalysts were able to mediate
intracellular bond breaking and bond forming processes. Likewise,
Bertozzi,6 Weissleder,7 and others pioneered the in vivo use of bio-
orthogonal Cu-free click reactions.
An attractive goal to extend the scope of such bio-functional
chemistries would now be to combine into a single molecular
system both the capabilities to react with an endogenous meta-
bolite (bio-specific reaction) and an exogenous reagent (bio-
orthogonal reaction). Such an endeavour relies on the chemist’s
ability to tweak the reactivity of functional groups and reagents in
order to make them functioning under the particular constraints of
complex biological media. For instance, such a molecular system
should demonstrate water solubility, water stability, fast reaction
kinetics at low concentration, bio-specificity and low toxicity. These
stringent operating constraints as well as the precise bio-selectivity
window required for such dual mode of activation make their
development an attractive challenge for organic chemists.
In this communication, we report our study on N-(dicyano-
methylene)aniline oxide that we found to be bio-specifically
reactive towards endogenous biothiols and bio-orthogonally
reactive towards sodium dithionite, a bio-compatible exogenous
reagent.8 We also found that reaction with any of the above
stimuli resulted in a strong hypsochromic shift of N-(dicyano-
methylene)aniline absorption. Based on this combination of
chemo and bio-functionalities, we report a novel concept of a
FRET probe which can be activated by either bio-specific or bio-
orthogonal bleaching of its quencher (Fig. 1).
Pro-fluorescent probes in complex biological media are acti-
vated via bio-specific reactions involving biothiols such as Michael
additions,9 aromatic nucleophilic additions,10 thiazolidine ring
formation,11 sulfonamide or sulfonate ester cleavage,12 disulfide
cleavage and addition–elimination that activates FRET-based
probes.13
It is noteworthy that even though the reported activation
mechanisms have allowed some degree of biospecific activation
Fig. 1 Principle of a FRET-based probe with a biologically and chemically
bleachable quencher. Metabolite-specific reaction shifts the quencher’s
absorption towards lower wavelengths and thus switches fluorescence on.
Further treatmentwith a bio-compatible exogenous reagent results in complete
bleaching of the quencher and consequently reveals the inactivate probes.
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to be obtained, none of them is compatible with subsequent
activation with an exogenous bio-orthogonal reagent. Following
reactivity screening, we have found that N-(dicyanomethylene)-
aniline oxide 1 (see Fig. 2), synthesized from nitroso aniline and
tetracyanoethylene, exhibits suitable features to become an
eﬀective chemo-bio-bleachable quencher.14
Firstly, nitrone 1 showed a maximum absorption at lmax =
552 nm (Fig. S1, ESI†). Such a high maximum absorption
wavelength overlaps with the emission spectrum of the tetra-
methylrhodamine (TAMRA), a widely used fluorophore that
absorbs at lmax = 550 nm and emits at lmax = 580 nm. Secondly,
we found that upon treatment of nitrone 1 (50 mM) with Cys
(1 mM) in phosphate buﬀer (0.1 M, pH 7.4) the absorption band
at 552 nm almost instantaneously disappeared with the con-
comitant and transient appearance of a new absorption band at
442 nm corresponding to the formation of a Cys-adduct (Fig. 2).
This shift of the maximum absorption peak would represent a
good fluorescence turn-on process of a nitrone-TAMRA FRET
probe. Along with this change in absorption, a solution of
nitrone 1 turned from dark purple to colourless (Fig. S4, ESI†).
Thirdly, the absorbance of compound 1 was instantaneously
neutralized upon treatment with sodium dithionite in phosphate
buﬀer (0.1 M, pH 7.4). This would be a smooth chemo-bleaching
process of the corresponding nitrone-TAMRA FRET probe. Finally,
MTT assays showed no inherent toxicity of nitrone 1 in HaCaT
cells under physiological conditions (Fig. S5, ESI†).
Synthesis of the nitrone-TAMRA FRET probe 7 started with the
preparation of intermediate 2 (Fig. 3). Amine alkylation between
N-methylaniline and methyl-4-bromobutyrate gave compound 2.
Nitrosation with sodium nitrite led to nitroso derivative 3. After
saponification, 4 reacted with tetracyanoethylene (TCN) to give 5.
Finally, coupling of 5 with TAMRA amine 6 gave the turn-on
fluorescent probe 7 after purification by semi-preparative HPLC.
To assess the chemoselectivity of N-(dicyanomethylene)-
aniline oxide moiety activation, probe 7 (1 mM) was treated
with various biological analytes (5 mM) including amino acids,
oxidizing and reducing agents, metal ions, glucose, nucleosides,
ascorbic acid and thiols (Cys, Hcy, and GSH) in phosphate buﬀer
(0.1 M, pH 7.4) (Fig. S10, ESI†). The results demonstrated a
significant fluorescence increase at 580 nm only upon reaction
with thiol derivatives. With all the other analytes, no real fluores-
cence emission enhancement was observed. This thiol-specific
reactivity was further confirmed by inhibiting the reaction with
iodoacetate, a thiol-alkylating agent (Fig. S11, ESI†). Next, our
probe 7 was reacted with increasing equivalents of cysteine and a
concentration-dependent increase in fluorescence response was
recorded. We calculated the detection limit for thiols of 50 nM
(Fig. S8, ESI†). We also measured a quantum yield of fluorescence
of 15% upon activation with cysteine (Fig. S12, ESI†). Bio-specific
and bio-orthogonal activation of probe 7 was then studied in living
cells. Probe 7 (40 mM) was incubated with normal embryonic fibro-
blast 3T3 cells for 1 h and with 3T3 cells, pre-treated with a-lipoic
acid (500 mM) for 48 h. The purpose of a-lipoic acid (ALA) is to
increase the intracellular level of reduced GSH.15 Fluorescence
emission was measured using a microplate reader (Fig. 4).
A sevenfold increase of intracellular fluorescence intensity was
observed in ALA treated cells compared to non-treated cells.
Then, ALA-3T3 cells were further treated with N-methylmaleimide
(NMM) to decrease the level of free thiols within the cells by
electrophilic alkylation and with buthionine sulfoximine (BSO),
a specific inhibitor of g-glutamylcysteine synthetase and therefore
a GSH synthesis inhibitor.16 Under both conditions fluorescence
intensity was found to be equivalent to that of untreated cells,
thus indicating that activation of probe 7 was indeed descriptive
of the intracellular level of free biothiols.
To validate the second mode of activation of probe 7, namely
bio-orthogonal chemical bleaching, sodium dithionite (10 mM)
was added to each one of the above-described assays (Fig. 5).
Finally, cells treated with probe 7 were imaged using con-
focal laser scanning microscopy. Cells were treated with blue
Fig. 2 Structure of nitrone 1 and absorption spectra of 1 (50 mM) upon
addition of Cys (1 mM) in phosphate buﬀer (0.1 M, pH 7.4) at 1, 5, 10, 30, 50,
80 and 100 min.
Fig. 3 Synthetic pathway for the formation of probe 7. Reagents and con-
ditions: (a) NaNO2, HCl, CH3OH, 0 1C, 30 min- 30 1C, 4 h (38%); (b) NaOH,
CH3OH, RT, overnight (87%); (c) TCN, DMF, RT, overnight (15%); (d) EDC,
HOBT, Et3N, DMF, RT, overnight (27%).
Fig. 4 Fluorescence of probe 7 (1 mM) incubated for 1 h with 3T3 cells,
treated under various conditions: CTL = untreated 3T3 cells; 7 = probe 7
with non-treated cells; 7 + ALA = probe 7 with cells pre-treated for 48 h
with ALA (500 mM); 7 + ALA + NMM = probe 7 with cells pre-treated for
48 h with ALA (500 mM), then treated for 30 min with NMM (500 mM);
7 + ALA + BSO = probe 7 with cells pre-treated for 48 h with ALA (500 mM)
then treated for 30 min with BSO (100 mM). Data were measured using a
microplate reader (excitation filter 530/25 nm; emission filter 590/35 nm).
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Hoechst-33258 dye to localize their nuclei. An intense intra-
cellular fluorescence was present in the cytosol. The recorded
images reveal that the probe can penetrate the cell membrane
and is present throughout the cytosol (Fig. 6a). As a control,
cells were treated with NMM prior to the addition of probe 7.
As expected in that case, only very weak fluorescence could be
observed (Fig. 6b). This shows that, in the absence of free bio-
thiol, none of the other components of biological media activates
the probe, thus illustrating the good bio-stability and bio-selectivity
of the N-(dicyanomethylene)aniline oxide motif.
In summary, we have reported the first molecular system
that is responsive to both a bio-specific and a bio-orthogonal
stimulus. This was visualized via activation of a FRET probe
through an original mechanism of quencher bleaching. Such a
combination of bio-functional reaction and quencher-based
fluorescence activation expands the repertoire of the turn-on/oﬀ
probe mechanism. It also illustrates one of the many-to-come
possibilities of using biofunctional chemistry to investigate bio-
logical systems with compact and multi-functional molecular tools.
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Fig. 5 Fluorescence of 7 in 3T3 cells under various conditions before
(green) and after (red) addition of dithionite (10 mM). CTL = untreated 3T3
cells; 7 = probe 7 with untreated cells; 7 + ALA = probe 7 with cells pre-
treated for 48 h with ALA (500 mM); 7 + ALA + NMM = probe 7 with cells
pre-treated for 48 h with ALA (500 mM) then treated for 30 min with NMM
(500 mM); 7 + ALA + BSO = probe 7with cells pre-treated for 48 h with ALA
(500 mM) then treated for 30 min with BSO (100 mM).
Fig. 6 Merged blue and red fluorescence images of living BNL CL.2 cells.
(a) BNL CL.2 cells were incubated with 1 mM of 7 for 1 h, then with Hoechst
33258 (5 mgmL1) for 30min. Fluorescence image of BNL CL.2 cells from the
blue and the red channels. (b) BNL CL.2 were pretreated with ALA (500 mM)
for 48 h, then with NMM (500 mM) for 20 min and finally incubated with 1 mM
of 7 for 1 h and with Hoechst 33258 for 30 min.
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